Jensen Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-5,410
Closed -$367K 92
2017
Q1
$367K Hold
5,410
0.01% 96
2016
Q4
$387K Sell
5,410
-450
-8% -$33.4K 0.01% 93
2016
Q3
$464K Buy
5,860
+940
+19% +$76.4K 0.01% 64
2016
Q2
$410K Buy
4,920
+490
+11% +$43.5K 0.01% 78
2016
Q1
$407K Buy
4,430
+660
+18% +$59.5K 0.01% 86
2015
Q4
$381K Sell
3,770
-390
-9% -$40.6K 0.01% 78
2015
Q3
$408K Sell
4,160
-480
-10% -$53.3K 0.01% 80
2015
Q2
$543K Sell
4,640
-650
-12% -$71K 0.01% 41
2015
Q1
$519K Buy
5,290
+30
+0.6% +$3.05K 0.01% 82
2014
Q4
$496K Buy
+5,260
New +$544K 0.01% 85

Other funds holding GILD

Jensen Investment Management's GILD Position: Q2 2017 in Review

Jensen Investment Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 5,410 shares — an estimated $367K sold.

Jensen Investment Management first reported a position in GILD in Q4 2014 and held it in 10 quarters. The position peaked at $543K in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Jensen Investment Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Jensen Investment Management sold 5,410 Gilead Sciences shares in Q2 2017, an estimated $367K.
  • Jensen Investment Management first reported a position in Gilead Sciences in Q4 2014 and held it in 10 quarters.
  • Jensen Investment Management's Gilead Sciences position peaked at $543K in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Jensen Investment Management's 13F filing for Q2 2017, filed 9 Aug 2017.